German firm Syntellix opens first overseas facility in Singapore
The orthopaedic implant maker projects that overall investment will reach S$200 million by 2024, with a potential cumulative revenue of S$500 million by then
Singapore
SYNTELLIX, a German firm that pioneered the use of bioabsorbable bone implants, opened its first overseas production site in Singapore on Tuesday, amid expectations of strong growth in the medical technology industry in this region.
While initial investment in the facility falls within an undisclosed "single-digit" million dollars, Syntellix founder, CEO and executive chairman Utz Claassen projected overall investment to reach S$200 million by 2024, with a potential cumulative revenue of S$500 million by then.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
SNP veteran John Swinney set to be Scotland’s next leader
Shell in talks to sell Malaysia fuel stations to Saudi Aramco: sources
Israel begins evacuating part of Rafah, Hamas decries 'dangerous escalation'
Macron, Von der Leyen press China’s Xi on trade in Paris talks
Eurozone business activity grows at fastest pace in almost a year, PMI shows
China May Day holiday spending delivers mixed picture on post-Covid recovery